EPIGRAL — Epigral Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹53.97bn
- IN₹59.56bn
- IN₹25.27bn
Annual cashflow statement for Epigral, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3,834 | 5,225 | 2,907 | 5,401 | 3,408 |
| Depreciation | |||||
| Non-Cash Items | 443 | 614 | 723 | 450 | 635 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,299 | -667 | -889 | -2,771 | -1,370 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,838 | 6,262 | 3,976 | 4,406 | 4,355 |
| Capital Expenditures | -4,563 | -4,165 | -3,984 | -1,947 | -3,942 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 16.7 | -208 | -26.7 | -669 | 395 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,546 | -4,372 | -4,011 | -2,616 | -3,547 |
| Financing Cash Flow Items | -480 | -605 | -720 | -743 | -487 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,952 | -1,998 | -76 | -1,635 | -945 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 244 | -108 | -111 | 155 | -136 |